JMJair Gonzalez Marques

Jair Gonzalez Marques

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jair Gonzalez Marques has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Changes in metabolomic profile in dogs with hepatic encephalopathy secondary to congenital portosystemic shunt suggests mitochondrial homeostasis disturbances

    by Ana Fernandez Gallego, Jair Marques, Dominic Kurian, Federico Diez, Richard J. Mellanby, Adam G. Gow, Alexander von Kriegsheim, Kiterie M. E. Faller

    Objective: To identify specific metabolomic changes in dogs showing signs of hepatic encephalopathy (HE) compared to those not showing obvious neurological signs and to follow these changes following medical treatment. Methods: In this prospective observational study, we recruited 10 client-owned dogs diagnosed with congenital portosystemic shunt (from March 2021 through October 2022). The sera of dogs with or without signs of HE at the time of diagnosis of congenital portosystemic shunt and following medical treatment for more than 4 weeks were analyzed by UPLC-MS. Results: Dogs showing signs of HE at the time of diagnosis (n = 6) had significantly lower serum concentrations of taurine (fold change [FC], 0.44), creatine (FC, 0.32), and guanine (FC, 0.45) and higher serum concentrations of 3-hydroxybenzaldehyde (FC, 2.51) than their counterparts not showing signs of HE (4). A marked albeit nonsignificant decrease in serum stearate concentrations was also observed in the HE group (FC, 0.12). Following medical treatment, which improved neurological signs, the concentrations of these metabolites, particularly taurine, normalized to concentrations similar to the non-HE group. Conclusions: Dogs with HE exhibit a different serum metabolomic profile compared to dogs without signs of HE. The main changes are suggesting disturbances in mitochondrial homeostasis in dogs suffering from HE. Clinical Relevance: Supporting mitochondrial function could form the basis of new therapeutic strategies in HE and merits further investigations in future studies.

  • Open Access

    Loss of DOCK2 potentiates Inflammatory Bowel Disease–associated colorectal cancer via immune dysfunction and IFNγ induction of IDO1 expression

    by Antonia M. D. Churchhouse, Caroline V. Billard, Toshiyasu Suzuki, Sebastian Ö. G. Pohl, Nora J. Doleschall, Kevin Donnelly, Colin Nixon, Mark J. Arends, Shahida Din, Kathryn Kirkwood, et al.

    Inflammatory Bowel Disease-associated colorectal cancer (IBD-CRC) is a known and serious complication of Inflammatory Bowel Disease (IBD) affecting the colon. However, relatively little is known about the pathogenesis of IBD-associated colorectal cancer in comparison with its sporadic cancer counterpart. Here, we investigated the function of Dock2, a gene mutated in ~10% of IBD-associated colorectal cancers that encodes a guanine nucleotide exchange factor (GEF). Using a genetically engineered mouse model of IBD-CRC, we found that whole body loss of Dock2 increases tumourigenesis via immune dysregulation. Dock2-deficient tumours displayed increased levels of IFNγ-associated genes, including the tryptophan metabolising, immune modulatory enzyme, IDO1, when compared to Dock2-proficient tumours. This phenotype was driven by increased IFNγ-production in T cell populations, which infiltrated Dock2-deficient tumours, promoting IDO1 expression in tumour epithelial cells. We show that IDO1 inhibition delays tumourigenesis in Dock2 knockout mice, and we confirm that this pathway is conserved across species as IDO1 expression is elevated in human IBD-CRC and in sporadic CRC cases with mutated DOCK2. Together, these data demonstrate a previously unidentified tumour suppressive role of DOCK2 that limits IFNγ-induced IDO1 expression and cancer progression, opening potential new avenues for therapeutic intervention.


  • Open Access

    Noise Stress induces Cardiovascular Metabolic Shifts

    by Jair G. Marques, Marin Kuntic, Roopesh Krishnankutty, Giovanny Rodriguez Blanco, Mykyta Malkov, Katie Frenis, Jimi Wills, Engy Shokry, Frederic Li Mow Chee, Cormac T Taylor, et al.

    Environmental stressors present in the modern world can fundamentally affect humans’ physiology and health. Exposure to stressors like air pollution, heat, and traffic noise has been linked to a pronounced increase in non-communicable diseases. Specifically, aircraft noise has been identified as a risk factor for cardiovascular and metabolic diseases, such as arteriosclerosis, heart failure, stroke, and diabetes. Noise stress leads to neuronal activation with subsequent stress hormone release that ultimately leads to activation of the renin-angiotensin-aldosterone system, increasing inflammation and oxidative stress, dramatically affecting the cardiovascular system. However, despite the epidemiological evidence of a link between noise stress and metabolic dysfunction, the consequences of exposure at the molecular, metabolic level of the cardiovascular system are largely unknown. Here we use a murine model system of aircraft noise exposure to show that noise stress profoundly alters heart metabolism. Within days of exposing animals to aircraft noise, the heart has a reduced potential for utilising fatty-acid beta-oxidation, the tricarboxylic acid cycle, and the electron transport chain for generating ATP. This is compensated by shifting energy production towards glycolysis. Intriguingly, the metabolic shift is reminiscent of what is observed in failing and ischaemic hearts. Our results demonstrate that within a relatively short exposure time, the cardiovascular system undergoes a fundamental metabolic shift that bears the hallmarks of cardiovascular disease. Overall, aircraft noise induces rapid, detrimental metabolic shifts in the heart, resembling patterns seen in cardiovascular diseases. These findings underscore the urgent need to comprehend the molecular consequences of environmental stressors, paving the way for targeted interventions aiming at mitigating health risks associated with chronic noise exposure in our modern, noisy environments.

  • Partial enteral nutrition has no benefit on bone health but improves growth in paediatric patients with quiescent or mild Crohn's disease

    by Annecarin Brückner, Katharina Julia Werkstetter, Klara Frivolt, Engy Shokry, Mohamed Ahmed, Amira Metwaly, Jair Gonzalez Marques, Olaf Uhl, Kathrin Krohn, Mohammad Hajji, et al.